AU2755192A - Preparations containing transition-metal compounds for anti-tumour therapy and/or stimulating the haematopoietic system - Google Patents

Preparations containing transition-metal compounds for anti-tumour therapy and/or stimulating the haematopoietic system

Info

Publication number
AU2755192A
AU2755192A AU27551/92A AU2755192A AU2755192A AU 2755192 A AU2755192 A AU 2755192A AU 27551/92 A AU27551/92 A AU 27551/92A AU 2755192 A AU2755192 A AU 2755192A AU 2755192 A AU2755192 A AU 2755192A
Authority
AU
Australia
Prior art keywords
metal compounds
preparations containing
stimulating
tumour therapy
containing transition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27551/92A
Inventor
Iduna Fichtner
Regina Reszka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Delbrueck Centrum fuer Molekulare in der Helmholtz Gemeinschaft
Original Assignee
Max Delbrueck Centrum fuer Molekulare in der Helmholtz Gemeinschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Delbrueck Centrum fuer Molekulare in der Helmholtz Gemeinschaft filed Critical Max Delbrueck Centrum fuer Molekulare in der Helmholtz Gemeinschaft
Publication of AU2755192A publication Critical patent/AU2755192A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention concerns the use of water-soluble or lipid-soluble transition-metal compounds in lyotrophic mesophases in order to stimulate the haematopoietic system and/or for anti-tumour therapy, as well as pharmaceutical preparations containing such compounds and their preparation. Thus with liposomal carboplatin, for instance, an above-average increase in leukocyte numbers was obtained.
AU27551/92A 1991-10-11 1992-10-09 Preparations containing transition-metal compounds for anti-tumour therapy and/or stimulating the haematopoietic system Abandoned AU2755192A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4134158 1991-10-11
DE4134158A DE4134158C2 (en) 1991-10-11 1991-10-11 Use of carboplatin in lyotrophic mesophases to overcome leukopenia caused by cytostatics

Publications (1)

Publication Number Publication Date
AU2755192A true AU2755192A (en) 1993-05-03

Family

ID=6442748

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27551/92A Abandoned AU2755192A (en) 1991-10-11 1992-10-09 Preparations containing transition-metal compounds for anti-tumour therapy and/or stimulating the haematopoietic system

Country Status (9)

Country Link
EP (1) EP0611303B1 (en)
JP (1) JP3627240B2 (en)
AT (1) ATE166576T1 (en)
AU (1) AU2755192A (en)
DE (2) DE4134158C2 (en)
DK (1) DK0611303T3 (en)
ES (1) ES2118831T3 (en)
GR (1) GR3027576T3 (en)
WO (1) WO1993006824A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19505960A1 (en) * 1995-02-21 1996-08-22 Deutsches Krebsforsch Conjugate for the individual dosage of drugs
DE60237162D1 (en) * 2001-10-03 2010-09-09 Celator Pharmaceuticals Inc LIPOSOMENIC LOADING WITH METALLIONS
KR100594353B1 (en) * 2002-05-28 2006-07-03 주식회사 엠디바이오알파 Active fraction having anti-cancer and anti-metastic activity isolated from leaves and stems of Ginseng

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3134709A1 (en) * 1981-09-02 1983-03-10 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz ANTINEOPLASTIC TITANIUM COMPOUND AND MEDICINAL PRODUCTS CONTAINING THEM
HU190579B (en) * 1984-07-18 1986-09-29 Nitrokemia Ipartelepek,Hu Plant growth regulating compositions comprising etherified hydroxy-alkyl-phosphonic acid-derivatives as active substance
DE3572981D1 (en) * 1984-07-24 1989-10-19 Asta Pharma Ag Ruthenium compounds having a tumor inhibiting activity
US4699978A (en) * 1985-01-18 1987-10-13 The Trustees Of Columbia University In The City Of New York Site-specific chiral ruthenium (II) and cobalt (III) antitumor agents
US5117022A (en) * 1985-10-18 1992-05-26 The Board Of Regents, The University Of Texas System Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
WO1991002531A1 (en) * 1989-08-17 1991-03-07 Peter Maccallum Cancer Institute Method for the modulation of haemopoiesis in a mammal

Also Published As

Publication number Publication date
DE4134158A1 (en) 1993-04-15
DE59209351D1 (en) 1998-07-02
JPH08508237A (en) 1996-09-03
JP3627240B2 (en) 2005-03-09
DE4134158C2 (en) 1997-02-13
DK0611303T3 (en) 1999-03-22
WO1993006824A1 (en) 1993-04-15
GR3027576T3 (en) 1998-11-30
EP0611303A1 (en) 1994-08-24
ATE166576T1 (en) 1998-06-15
EP0611303B1 (en) 1998-05-27
ES2118831T3 (en) 1998-10-01

Similar Documents

Publication Publication Date Title
CA2068324A1 (en) Metal-peptide compositions and methods for stimulating hair growth
AU6680586A (en) Insecticidal pyrazolines
AP9901435A0 (en) Bicycle heteroaromatic compounds as protein tyrosine kinase inhibitors.
EP0283713A3 (en) Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them
MX9605665A (en) Bis(resorcinyl)triazines.
HK160995A (en) Complex compounds of bioflavonoids with phospholipids their preparation and use and pharmaceutical and cosmetic compositions containing them
ZA975437B (en) New pyridyl alkene and pyridyl alkine acid amides.
IL107109A0 (en) Compounds for modifying drug resistance and pharmaceutical compositions containing the same
NZ258019A (en) Medicinal compositions containing potassium, zinc, calcium and rubidium ions having the same properties as oak bark extract
MY109990A (en) Microfluidised particles of atovaquone and pharmaceutical preparation thereof
IL89840A0 (en) Substituted flavonoid compounds and salts thereof,their preparation and pharmaceutical compositions containing them
IE873125L (en) Benzimidazole derivatives
ES8502405A1 (en) Perfluorocarbon emulsions and their preparation and use in therapy.
BG103261A (en) The use of 1-hydroxy-2-pyridon for the treatment of skin diseases
ZA943553B (en) Tri(platinum) complexes
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
AU2755192A (en) Preparations containing transition-metal compounds for anti-tumour therapy and/or stimulating the haematopoietic system
BG103260A (en) The application of 1-hydroxy-2-pyridons for the treatment of seborrheic dermatitis
MD457G2 (en) New naphtiridin derivatives , preparation method, pharmaceutical compositions containing these derivatives, their utilization as antireproductive medicines
AU4042795A (en) Treatment of non-small cell lung carcinoma
MY107258A (en) 1-methoxypyrimidinyl-n-nitrophenyl-1h-1,2,4-triazole-3- sulphonamides, processes for their preparation and their use as herbicides.
ATE87314T1 (en) PLATINUM MEDICINES.
KR0177821B1 (en) Pharmaceutical compositions containing 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans
ES2106858T3 (en) NEW DERIVATIVES OF CYTARABINE, ITS PREPARATION PROCEDURE AND ITS USE AGAINST CANCER DISEASES.
UA38332A (en) Heteropolynuclear complexes of Al and Zn tetrakis-(3-pyridyloxy)-phthalocyanins containing cisplatinum groups with combined photodynamic activity and cytotoxicity